Advisory: Alert on Tetra Bio-Pharma's CFO appointment withdrawn
June 25 (Reuters) - Alert on Tetra Bio-Pharma's Chief
Financial Officer appointment is wrong and has been withdrawn as
it was auto-published inadvertently from a press release issued
by the company.
For the correct alerts, click urn:newsml:reuters.com:*:nFWN2O70SL
STORY_NUMBER: TUA6ctDNV
STORY_DATE: 25/06/2021
STORY_TIME: 10:50:19
((Bangalore.newsroom@thomsonreuters.com))
Recent news on Tetra Bio Pharma
See all newsBrief: Tetra Bio Receives A Second Clarifax From Health Canada Regarding Reduvo Risk Management Plan
Brief: Tetra Bio-Pharma Announces Results Of Artificial Intelligence Study Of ARDS-003 Combined With Favipiravir
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra And Prepaire Jointly Apply To Barda For Funding